Journal article
Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study
Abstract
PURPOSE: 2-[(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) is potentially useful in assessing lymph nodes and detecting distant metastases in women with primary breast cancer.
PATIENTS AND METHODS: Women diagnosed with operable breast cancer within 3 months underwent FDG-PET at one of five Ontario study centers followed by axillary lymph node assessment (ALNA) consisting of sentinel lymph node biopsy (SLNB) alone if sentinel …
Authors
Pritchard KI; Julian JA; Holloway CMB; McCready D; Gulenchyn KY; George R; Hodgson N; Lovrics P; Perera F; Elavathil L
Journal
Journal of Clinical Oncology, Vol. 30, No. 12, pp. 1274–1279
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
April 20, 2012
DOI
10.1200/jco.2011.38.1103
ISSN
0732-183X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overAxillaBiopsy, NeedleBreast NeoplasmsConfidence IntervalsFemaleFluorodeoxyglucose F18HumansLogistic ModelsLymph Node ExcisionLymph NodesLymphatic MetastasisMiddle AgedNeoplasm StagingOntarioPositron-Emission TomographyPredictive Value of TestsProspective StudiesSensitivity and SpecificitySentinel Lymph Node Biopsy